Detalhe da pesquisa
1.
Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in acute myeloid leukemia evolving from myelodysplastic syndromes: a pilot study.
Leukemia
; 8(10): 1631-9, 1994 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-7934158
2.
Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Leukemia
; 10(4): 662-8, 1996 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-8618444
3.
No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease.
Leukemia
; 17(9): 1827-33, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12970783
4.
Classical morphology, esterase cytochemistry, and interphase cytogenetics of peripheral blood and bone marrow smears.
J Histochem Cytochem
; 44(11): 1303-9, 1996 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-8918905
5.
A sequential erythropoietin and GM-CSF schedule offers clinical benefits in the treatment of anaemia in myelodysplastic syndromes.
Leuk Res
; 20(8): 693-9, 1996 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-8913323
6.
Long-term follow-up of 18 patients with myelodysplastic syndromes responding to recombinant erythropoietin treatment.
Leuk Res
; 25(1): 13-18, 2001 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11137555
7.
Tumor necrosis factor-alpha and interferon-gamma in serum of multiple myeloma patients.
Anticancer Res
; 10(3): 817-20, 1990.
Artigo
em Inglês
| MEDLINE | ID: mdl-2114819
8.
[Genetic origin of malignant hematopoiesis well defined]. / Den maligna hematopoesens genetiska ursprung väl kartlagt.
Lakartidningen
; 95(48): 5493-4, 5497-8, 1998 Nov 25.
Artigo
em Sueco
| MEDLINE | ID: mdl-9854375
9.
Minimal diagnostic criteria for the myelodysplastic syndrome in clinical practice.
Leuk Res
; 16(1): 8-9, 1992.
Artigo
em Inglês
| MEDLINE | ID: mdl-1732679
10.
Deletion of chromosome 2(p13) is a nonrandomly occurring karyotypic abnormality in myelodysplastic syndrome.
Cancer Genet Cytogenet
; 59(1): 97-8, 1992 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-1555201
11.
[The man behind the syndrome: Eli Moschkowitz. In hospitals people should be treated, not the disease]. / Mannen bakom syndromet: Eli Moschcowitz. "På sjukhus skall man behandla människor, inte sjukdomar".
Lakartidningen
; 83(50): 4291-2, 1986 Dec 10.
Artigo
em Sueco
| MEDLINE | ID: mdl-3543567
12.
Hematopoietic growth factors for the treatment of myelodysplastic syndromes.
Acta Haematol Pol
; 22(2): 203-7, 1991.
Artigo
em Inglês
| MEDLINE | ID: mdl-1726768
13.
Aplastic anaemia with a trilineage response to erythropoietin therapy.
J Intern Med
; 239(1): 79-81, 1996 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-8551205
14.
Promising activity of gemcitabine in refractory high-grade non-Hodgkin's lymphoma.
Br J Haematol
; 101(1): 203-4, 1998 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-9576202
15.
Cimetidine as an immune response modifier.
Med Oncol Tumor Pharmacother
; 6(1): 111-3, 1989.
Artigo
em Inglês
| MEDLINE | ID: mdl-2657245
16.
Gain of chromosome 7, which marks the progression from indolent to aggressive follicle centre lymphomas, is restricted to the B-lymphoid cell lineage: a study by FISH in combination with morphology and immunocytochemistry.
Br J Haematol
; 105(4): 1140-4, 1999 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-10554835
17.
Fluorescence in situ hybridization in combination with morphology detects minimal residual disease in remission and heralds relapse in acute leukaemia.
Br J Haematol
; 95(4): 666-72, 1996 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-8982043
18.
Differences in cell lineage involvement between MDS-AML and de novo AML studied by fluorescence in situ hybridization in combination with morphology.
Eur J Haematol
; 58(4): 241-5, 1997 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-9186534
19.
Gain of chromosome 7 marks the progression from indolent to aggressive follicle centre lymphoma and is a common finding in patients with diffuse large B-cell lymphoma: a study by FISH.
Br J Haematol
; 101(3): 487-91, 1998 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-9633892
20.
Increase of serum interleukin-2 and regression of myeloma after rhGM-CSF treatment of drug induced bone marrow aplasia.
Hematol Oncol
; 9(3): 129-35, 1991.
Artigo
em Inglês
| MEDLINE | ID: mdl-1937405